Changes in bone remodeling rate influence the degree of mineralization of bone which is a determinant of bone strength: therapeutic implications.
Boivin
G
G
INSERM Unité 403, Faculté de Medicine R. Laennec and Hopital Edouard Herriot, Lyon, France.
Meunie
P J
PJ
D000328:Adult; D019386:Alendronate / Q000627:therapeutic use; D001696:Biomechanical Phenomena; D015519:Bone Density / Q000187:drug effects; D016723:Bone Remodeling / Q000187:drug effects; D001842:Bone and Bones / Q000187:drug effects / Q000502:physiology*; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology
D019386:Alendronate